Tapewire

NYSE · USD

VNRX

VOLITIONRX LTD

Export transactions ↓
Tapewire entity
8241
SEC CIK
0000093314
Parsed reports
530

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2023 Filed Feb 23, 2023 20:54 UTC PurchaseCommon Stock 58,500 $1.75 $102,375.00
Disclosure

SEC source: 0001477932-23-001225 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 154,503

F1 · shares: Acquired by the reporting person's child at the public offering price in the public offering of common stock by the Company. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: Acquired by the reporting person's child at the public offering price in the public offering of common stock by the Company. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:03 UTC
Hughes TerigChief Financial Officer
GrantCommon Stock 20,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000276 · form4.xml · nonDerivative · entry 1

Hughes Terig · CIK 0001841309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,990

F1 · shares: On October 4, 2022, the reporting person was awarded 55,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 20,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 6,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 9,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:03 UTC
Plummer NicholasGC - Volition Diagnostics
GrantCommon Stock 19,500 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000273 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,994

F1 · shares: On October 4, 2022, the reporting person was awarded 52,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 19,500 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 6,500 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 9,100 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:05 UTC GrantCommon Stock 12,375 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000278 · form4.xml · nonDerivative · entry 1

Rootsaert Rodney Gerard · CIK 0001577894 · Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,652

F1 · shares: On October 4, 2022, the reporting person was awarded 33,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,375 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,125 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 5,775 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:04 UTC
Butera Salvatore ThomasCEO - Volition Veterinary
GrantCommon Stock 24,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000277 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO - Volition Veterinary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,200

F1 · shares: On October 4, 2022, the reporting person was awarded 64,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 24,000 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 8,000 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 11,200 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:03 UTC GrantCommon Stock 5,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000275 · form4.xml · nonDerivative · entry 1

Brudnick Richard · CIK 0001692359 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,936

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:03 UTC GrantCommon Stock 5,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000274 · form4.xml · nonDerivative · entry 1

Barnes Phillip · CIK 0001790293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,936

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:03 UTC
Colman AlanDirector
GrantCommon Stock 5,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000272 · form4.xml · nonDerivative · entry 1

Colman Alan · CIK 0001577873 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,529

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:03 UTC GrantCommon Stock 14,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000271 · form4.xml · nonDerivative · entry 1

Faulkes Martin Charles · CIK 0001577872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,651,693

F1 · shares: On October 4, 2022, the reporting person was awarded 39,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 14,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 6,825 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:02 UTC
Nguyen KimDirector
GrantCommon Stock 5,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000270 · form4.xml · nonDerivative · entry 1

Nguyen Kim · CIK 0001852492 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,436

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:02 UTC
Kway JasmineCEO - Singapore Volition
GrantCommon Stock 18,375 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000269 · form4.xml · nonDerivative · entry 1

Kway Jasmine · CIK 0001808135 · CEO - Singapore Volition

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,390

F1 · shares: On October 4, 2022, the reporting person was awarded 49,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 18,375 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 6,125 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 8,575 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:02 UTC
Micallef Jacob VincentChief Scientific Officer
GrantCommon Stock 14,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000268 · form4.xml · nonDerivative · entry 1

Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,017

F1 · shares: On October 4, 2022, the reporting person was awarded 39,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 14,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 6,825 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:02 UTC
Batchelor Ann-LouiseGroup Chief Marketing Officer
GrantCommon Stock 14,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000267 · form4.xml · nonDerivative · entry 1

Batchelor Ann-Louise · CIK 0001945612 · Group Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,358

F1 · shares: On October 4, 2022, the reporting person was awarded 39,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 14,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 6,825 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:02 UTC GrantCommon Stock 5,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000266 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,570,411

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:02 UTC
Michel GaetanChief Operating Officer
GrantCommon Stock 27,750 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000265 · form4.xml · nonDerivative · entry 1

Michel Gaetan · CIK 0001709503 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,697

F1 · shares: On October 4, 2022, the reporting person was awarded 74,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 27,750 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,250 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 12,950 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:01 UTC
Forterre GaelChief Commerical Officer
GrantCommon Stock 17,250 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000264 · form4.xml · nonDerivative · entry 1

Forterre Gael · CIK 0001841637 · Chief Commerical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,675

F1 · shares: On October 4, 2022, the reporting person was awarded 46,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 17,250 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 5,750 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 8,050 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:01 UTC GrantCommon Stock 5,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000263 · form4.xml · nonDerivative · entry 1

Futcher Edward · CIK 0001222623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,186

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
January 12, 2023 Filed Jan 13, 2023 21:01 UTC
Reynolds Cameron JohnDirector · President and CEO
GrantCommon Stock 33,375 $0.00 $0.00
Disclosure

SEC source: 0001477932-23-000262 · form4.xml · nonDerivative · entry 1

Reynolds Cameron John · CIK 0001340610 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,444,468

F1 · shares: On October 4, 2022, the reporting person was awarded 89,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 33,375 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,125 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 15,575 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

Read SEC document
December 19, 2022 Filed Dec 20, 2022 15:30 UTC
Butera Salvatore ThomasCEO - Volition Veterinary
PurchaseCommon Stock 5,000 $2.27 $11,350.00
Disclosure

SEC source: 0001477932-22-009425 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO - Volition Veterinary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,350

F1 · ownership.direct: These shares of common stock are jointly owned by the reporting person and his spouse.

Read SEC document
December 19, 2022 Filed Dec 20, 2022 15:04 UTC
Micallef Jacob VincentChief Scientific Officer
PurchaseCommon Stock 25,000 $2.30 $57,500.00
Disclosure

SEC source: 0001477932-22-009423 · form4.xml · nonDerivative · entry 2

Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,392

Read SEC document
December 16, 2022 Filed Dec 19, 2022 14:59 UTC PurchaseCommon Stock 55,000 $2.10 $115,500.00
Disclosure

SEC source: 0001477932-22-009385 · form4.xml · nonDerivative · entry 1

Faulkes Martin Charles · CIK 0001577872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,637,068

Read SEC document
December 16, 2022 Filed Dec 20, 2022 15:04 UTC
Micallef Jacob VincentChief Scientific Officer
PurchaseCommon Stock 7,339 $1.96 $14,384.44
Disclosure

SEC source: 0001477932-22-009423 · form4.xml · nonDerivative · entry 1

Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,392

Read SEC document
December 12, 2022 Filed Dec 13, 2022 14:59 UTC
Butera Salvatore ThomasCEO - Volition Veterinary
PurchaseCommon Stock 4,350 $2.09 $9,091.50
Disclosure

SEC source: 0001477932-22-009249 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO - Volition Veterinary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,350

F1 · ownership.direct: These shares of common stock are jointly owned by the reporting person and his spouse.

Read SEC document
December 08, 2022 Filed Dec 12, 2022 14:53 UTC
Plummer NicholasGC - Volition Diagnostics
PurchaseCommon Stock 4,800 $2.07 $9,936.00
Disclosure

SEC source: 0001477932-22-009221 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,494

Read SEC document
November 28, 2022 Filed Nov 29, 2022 15:57 UTC
Butera Salvatore ThomasCEO - Volition Veterinary
PurchaseCommon Stock 5,000 $2.21 $11,050.00
Disclosure

SEC source: 0001477932-22-008934 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO - Volition Veterinary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,000

F1 · ownership.direct: These shares of common stock are jointly owned by the reporting person and his spouse.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC GiftCommon Stock 12,432 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 9

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By daughter

Disclosed balance after: 96,004

F2 · shares: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

F2 · ownership.nature: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC GiftCommon Stock 12,432 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 8

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By daughter

Disclosed balance after: 96,004

F2 · shares: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

F2 · ownership.nature: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC GiftCommon Stock 12,431 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 7

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 96,003

F2 · shares: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

F2 · ownership.nature: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC GiftCommon Stock 12,431 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 6

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 96,003

F2 · shares: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

F2 · ownership.nature: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC GiftCommon Stock 49,726 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 5

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Bare Trust

Disclosed balance after: 0

F2 · shares: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

F2 · ownership.nature: The foregoing shares were held by a bare trust, which was not a separate legal entity, of which the reporting person was the Trustee, for the benefit of his children. The bare trust was wound up and the securities transferred to the children of the reporting person.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC OtherCommon Stock 8,572 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 4

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By daughter

Disclosed balance after: 83,572

F1 · shares: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC OtherCommon Stock 8,572 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 3

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By daughter

Disclosed balance after: 83,572

F1 · shares: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC OtherCommon Stock 8,572 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 2

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 83,572

F1 · shares: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 10, 2022 Filed Nov 10, 2022 21:05 UTC OtherCommon Stock 8,572 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-008314 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 83,572

F1 · shares: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: Bequeathed to the children of the reporting person by parties other than the reporting person pursuant to the terms of a will. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 20:01 UTC
Plummer NicholasGC - Volition Diagnostics
Tax withholdingCommon Stock 9,406 $1.97 $18,529.82
Disclosure

SEC source: 0001477932-22-008141 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,694

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,750 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:11 UTC GrantCommon Stock 2,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007706 · form4.xml · nonDerivative · entry 1

Futcher Edward · CIK 0001222623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,561

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:10 UTC
Colman AlanDirector
GrantCommon Stock 2,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007705 · form4.xml · nonDerivative · entry 1

Colman Alan · CIK 0001577873 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,904

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:08 UTC
Reynolds Cameron JohnDirector · President and CEO
GrantCommon Stock 15,575 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007704 · form4.xml · nonDerivative · entry 1

Reynolds Cameron John · CIK 0001340610 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,411,093

F1 · shares: On October 4, 2022, the reporting person was awarded 89,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 15,575 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 5,192 units, 5,192 units, and 5,191 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:07 UTC
Batchelor Ann-LouiseGroup Chief Marketing Officer
GrantCommon Stock 6,825 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007702 · form4.xml · nonDerivative · entry 1

Batchelor Ann-Louise · CIK 0001945612 · Group Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,733

F1 · shares: On October 4, 2022, the reporting person was awarded 39,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 6,825 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 2,275 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:08 UTC
Hughes TerigChief Financial Officer
GrantCommon Stock 9,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007703 · form4.xml · nonDerivative · entry 1

Hughes Terig · CIK 0001841309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,365

F1 · shares: On October 4, 2022, the reporting person was awarded 55,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 9,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 3,209 units, 3,208 units, and 3,208 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:07 UTC
Butera Salvatore ThomasCEO - Volition Veterinary
GrantCommon Stock 11,200 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007701 · form4.xml · nonDerivative · entry 1

Butera Salvatore Thomas · CIK 0001834339 · CEO - Volition Veterinary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,200

F1 · shares: On October 4, 2022, the reporting person was awarded 64,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 11,200 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 3,734 units, 3,733 units, and 3,733 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:06 UTC GrantCommon Stock 5,775 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007700 · form4.xml · nonDerivative · entry 1

Rootsaert Rodney Gerard · CIK 0001577894 · Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,277

F1 · shares: On October 4, 2022, the reporting person was awarded 33,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,775 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,925 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:06 UTC GrantCommon Stock 2,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007699 · form4.xml · nonDerivative · entry 1

Brudnick Richard · CIK 0001692359 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,311

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:05 UTC GrantCommon Stock 2,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007698 · form4.xml · nonDerivative · entry 1

Barnes Phillip · CIK 0001790293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,311

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:04 UTC
Plummer NicholasGC - Volition Diagnostics
GrantCommon Stock 9,100 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007697 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,100

F1 · shares: On October 4, 2022, the reporting person was awarded 52,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 9,100 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 3,034 units, 3,033 units, and 3,033 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:04 UTC
Forterre GaelChief Commercial Officer
GrantCommon Stock 8,050 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007696 · form4.xml · nonDerivative · entry 1

Forterre Gael · CIK 0001841637 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,425

F1 · shares: On October 4, 2022, the reporting person was awarded 46,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 8,050 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 2,684 units, 2,683 units, and 2,683 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:03 UTC
Michel GaetanChief Operating Officer
GrantCommon Stock 12,950 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007695 · form4.xml · nonDerivative · entry 1

Michel Gaetan · CIK 0001709503 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,947

F1 · shares: On October 4, 2022, the reporting person was awarded 74,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,950 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 4,317 units, 4,317 units, and 4,316 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:02 UTC
Micallef Jacob VincentChief Scientific Officer
GrantCommon Stock 6,825 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007693 · form4.xml · nonDerivative · entry 1

Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,053

F1 · shares: On October 4, 2022, the reporting person was awarded 39,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 6,825 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 2,275 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:03 UTC GrantCommon Stock 2,625 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007694 · form4.xml · nonDerivative · entry 1

Innes Guy Archibald · CIK 0001579377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,564,786

F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document
October 13, 2022 Filed Oct 14, 2022 20:01 UTC
Kway JasmineCEO - Singapore Volition
GrantCommon Stock 8,575 $0.00 $0.00
Disclosure

SEC source: 0001477932-22-007692 · form4.xml · nonDerivative · entry 1

Kway Jasmine · CIK 0001808135 · CEO - Singapore Volition

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,015

F1 · shares: On October 4, 2022, the reporting person was awarded 49,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 8,575 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 2,859 units, 2,858 units, and 2,858 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.